Cargando…

SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma

BACKGROUND AND OBJECTIVE: Serine hydroxymethyltransferase 2 (SHMT2) functions as a key enzyme in serine/glycine biosynthesis and one-carbon metabolism. Recent studies have shown that SHMT2 participated in tumor growth and progression in a variety of cancer types. The objective of the present study i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Shanglei, Ma, Siquan, Saleh, Abdul Qahar, Guo, Lingyu, Zhao, Zixiao, Chen, Yuxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136477/ https://www.ncbi.nlm.nih.gov/pubmed/30228815 http://dx.doi.org/10.1155/2018/4369253

Ejemplares similares

Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018)

Overexpression of the X-linked ribosomal protein S4 predicts poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Kuang, Jie, et al.
Publicado: (2017)

Long non-coding RNA ZEB1-AS1 predicts a poor prognosis and promotes cancer progression through the miR-200a/ZEB1 signaling pathway in intrahepatic cholangiocarcinoma
por: Jiao, Mingwen, et al.
Publicado: (2020)

Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer
por: Zhang, Peng, et al.
Publicado: (2021)

High level of CD73 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Xu, Ya-ping, et al.
Publicado: (2021)

Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
por: Peng, Jianbo, et al.
Publicado: (2023)

Flotillin-2 predicts poor prognosis and promotes tumor invasion in intrahepatic cholangiocarcinoma
por: Xu, Zhiying, et al.
Publicado: (2020)

WWP1 upregulation predicts poor prognosis and promotes tumor progression by regulating ubiquitination of NDFIP1 in intrahepatic cholangiocarcinoma
por: Li, Yongjian, et al.
Publicado: (2022)

CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis
por: Miyata, Tatsunori, et al.
Publicado: (2019)

Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2022)

Overexpression of long non-coding RNA CRNDE facilitates epithelial-mesenchymal transition and correlates with poor prognosis in intrahepatic cholangiocarcinoma
por: Xia, Xiu-Liang, et al.
Publicado: (2018)

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
por: Sha, Meng, et al.
Publicado: (2019)

Prognostic Significance of Capn4 Overexpression in Intrahepatic Cholangiocarcinoma
por: Zhang, Chi, et al.
Publicado: (2013)

Down-regulation of lncRNA-NEF indicates poor prognosis in intrahepatic cholangiocarcinoma
por: Liang, Zhanqiang, et al.
Publicado: (2019)

Overexpression of SEZ6L2 predicts poor prognosis in patients with cholangiocarcinoma
por: Wang, Ziming, et al.
Publicado: (2020)

Effect of age on the prognosis of intrahepatic cholangiocarcinoma
por: Kim, Jung Hun, et al.
Publicado: (2023)

The impact of decreased expression of SVEP1 on abnormal neovascularization and poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Chen, Liwei, et al.
Publicado: (2023)

CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
por: Cai, Xiaobo, et al.
Publicado: (2018)

Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2020)

Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma
por: Ong, Khaa Hoo, et al.
Publicado: (2023)

Biomarkers for predicting the prognosis of intrahepatic cholangiocarcinoma: A retrospective single-center study
por: Li, Xueliang, et al.
Publicado: (2023)

Personalized intrahepatic cholangiocarcinoma prognosis prediction using radiomics: Application and development trend
por: Chen, Pengyu, et al.
Publicado: (2023)

High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Song, Jian-Ping, et al.
Publicado: (2022)

Overexpression of 14-3-3δ Predicts Poor Prognosis in Extrahepatic Cholangiocarcinoma Patients
por: Wu, Qiao, et al.
Publicado: (2020)

High expression of Oct4 and Nanog predict poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection
por: Zhang, Mei-xia, et al.
Publicado: (2019)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma
por: Xu, Linping, et al.
Publicado: (2022)

A novel model for predicting the prognosis of postoperative intrahepatic cholangiocarcinoma patients
por: Lv, Yinghao, et al.
Publicado: (2023)

Sarcomatoid intrahepatic cholangiocarcinoma in a patient with poor prognosis: a case report and literature review
por: Li, Xu, et al.
Publicado: (2020)

Upregulated expression of HOXB7 in intrahepatic cholangiocarcinoma is associated with tumor cell metastasis and poor prognosis
por: Dai, Longfei, et al.
Publicado: (2019)

Autophagy Plays a Role in the CUL4A-Related Poor Prognosis of Intrahepatic Cholangiocarcinoma
por: Weng, Shao-Wen, et al.
Publicado: (2021)

Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance
por: Peng, Rui, et al.
Publicado: (2017)

Preoperative risk grade predicts the long-term prognosis of intrahepatic cholangiocarcinoma: a retrospective cohort analysis
por: Zhao, Jianping, et al.
Publicado: (2021)

Declined Preoperative Aspartate Aminotransferase to Neutrophil Ratio Index Predicts Poor Prognosis in Patients with Intrahepatic Cholangiocarcinoma after Hepatectomy
por: Liu, Lingyun, et al.
Publicado: (2018)

Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma
por: Wu, Zhi-Zhong, et al.
Publicado: (2020)

High expression of HVEM is associated with improved prognosis in intrahepatic cholangiocarcinoma
por: Ma, Bingqi, et al.
Publicado: (2021)

Metadherin overexpression in perihilar cholangiocarcinoma is associated with lymph node metastasis and poor prognosis
por: Zhu, Yan-Zhi, et al.
Publicado: (2019)

SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate Biosynthesis
por: Anderson, Donald D., et al.
Publicado: (2009)

High Expression of Protein Tyrosine Kinase 7 Significantly Associates with Invasiveness and Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Jin, Jing, et al.
Publicado: (2014)

IL23R as an indicator of immune infiltration and poor prognosis in intrahepatic cholangiocarcinoma: a bioinformatics analysis
por: Zhang, Lin-Ting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tfsr7jpamqhlv2s727ra3j12oh